5 O
WARNINGS O
AND O
PRECAUTIONS O
EXCERPT O
: O
Hypersensitivity O
: O
Ask O
patients O
about O
prior O
reactions O
to O
drugs O
, O
especially O
dextran O
or O
modified O
forms O
of O
dextran O
. O

Observe O
for O
hypersensitivity O
signs O
and O
symptoms O
following O
Lymphoseek O
injection O
. O

Have O
resuscitation O
equipment O
and O
trained O
personnel O
immediately O
available O
. O

( O
5.1 O
) O
5.1 O
Hypersensitivity O
Reactions O
Lymphoseek O
may O
pose O
a O
risk O
of O
hypersensitivity B-OSE_Labeled_AE
reactions I-OSE_Labeled_AE
due I-OSE_Labeled_AE
to I-OSE_Labeled_AE
its I-OSE_Labeled_AE
chemical I-OSE_Labeled_AE
similarity I-OSE_Labeled_AE
to O
dextran O
[ O
see O
Description O
( O
11 O
) O
] O
. O

Serious O
hypersensitivity B-NonOSE_AE
reactions I-NonOSE_AE
have O
been O
associated O
with O
dextran O
and O
modified O
forms O
of O
dextran O
( O
such O
as O
iron O
dextran O
drugs O
) O
. O

Before O
administering O
Lymphoseek O
, O
ask O
patients O
about O
prior O
hypersensitivity B-NonOSE_AE
reactions I-NonOSE_AE
to O
drugs O
, O
especially O
to O
dextran O
and O
modified O
forms O
of O
dextran O
. O

Have O
resuscitation O
equipment O
and O
trained O
personnel O
immediately O
available O
at O
the O
time O
of O
Lymphoseek O
administration O
. O

5.2 O
Radiation O
Risks O
Any O
radiation-emitting O
product O
may O
increase O
the O
risk B-NonOSE_AE
for I-NonOSE_AE
cancer I-NonOSE_AE
, O
especially O
in O
pediatric O
patients O
. O

Adhere O
to O
the O
dose O
recommendations O
and O
ensure O
safe O
handling O
to O
minimize O
the O
risk O
for O
excessive O
radiation B-NonOSE_AE
exposure I-NonOSE_AE
to O
either O
patients O
or O
health O
care O
workers O
. O

